| Epithelial barrier hypothesis: effect of external exposome on microbiome and epithelial barriers in allergic disease Z Celebi Sozener, B Ozdel Ozturk, P Cerci, M Turk, B Gorgulu, M Akdis, ... Allergy, 2022 | 260 | 2022 |
| The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and Cystatin C in early diagnosis of septic acute kidney injury in critically ill patients M Aydoğdu, G Gürsel, B Sancak, S Yeni, G Sarı, S Taşyürek, M Türk, ... Disease markers 34 (4), 237-246, 2013 | 115 | 2013 |
| How to treat patients with chronic spontaneous urticaria with omalizumab: Questions and answers M Türk, L Carneiro-Leão, P Kolkhir, H Bonnekoh, T Buttgereit, M Maurer The Journal of Allergy and Clinical Immunology: In Practice 8 (1), 113-124, 2020 | 81 | 2020 |
| Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients M Türk, İ Yılmaz, SN Bahçecioğlu Allergology International 67 (1), 85-89, 2018 | 68 | 2018 |
| The external exposome and allergies: from the perspective of the epithelial barrier hypothesis Z Celebi Sozener, Ü Özbey Yücel, S Altiner, B Ozdel Oztürk, P Cerci, ... Frontiers in allergy 3, 887672, 2022 | 42 | 2022 |
| Mast cells, cortistatin, and its receptor, MRGPRX2, are linked to the pathogenesis of chronic prurigo P Kolkhir, P Pyatilova, T Ashry, Q Jiao, AT Abad-Perez, S Altrichter, ... Journal of Allergy and Clinical Immunology 149 (6), 1998-2009. e5, 2022 | 42 | 2022 |
| How to discontinue omalizumab in chronic spontaneous urticaria? M Türk, M Maurer, İ Yılmaz Allergy, 2018 | 34 | 2018 |
| Two-week intervals during omalizumab treatment may provide better symptom control in selected patients with chronic urticaria M Türk, E Kocatürk, K Cüre, İ Yılmaz The Journal of Allergy and Clinical Immunology: In Practice 6 (4), 1389-1390, 2018 | 33 | 2018 |
| Efficacy of mepolizumab treatment in oral corticosteroid-dependent severe eosinophilicasthma patients with chronic rhinosinusitis with nasal polyps: single center, real life study I Yilmaz, M Türk, SN Bahçecioğlu, N Tutar, İ Gülmez Turkish Journal of Medical Sciences 50 (2), 433-441, 2020 | 29 | 2020 |
| Tracheal Papilloma Treated with Cryotherapy and Interferon-α: A Case Report and Review of the Literature F Yıldırım, M Türk, S Demircan, N Akyürek, AS Yurdakul Case reports in pulmonology 2015, 2015 | 21 | 2015 |
| Successful rapid subcutaneous desensitization to anakinra in a case with a severe immediate-type hypersensitivity reaction. I YIlmaz, M Türk, SB Nazik European annals of allergy and clinical immunology 50 (2), 94-96, 2018 | 20 | 2018 |
| Effects of Modes, Obesity, and Body Position on Non-invasive Positive Pressure Ventilation Success in the Intensive Care Unit: A Randomized Controlled Study M Türk, M Aydoğdu, G Gürsel Turk Thorac J 19, 36-40, 2018 | 19 | 2018 |
| Experience‐based advice on stepping up and stepping down the therapeutic management of chronic spontaneous urticaria: Where is the guidance? M Türk, İ Yılmaz, ÜM Şahiner, E Kocatürk, BE Şekerel, T Zuberbier, ... Allergy, 2022 | 17 | 2022 |
| Discontinuing Omalizumab Treatment in Super-Responder Patients with Allergic Severe Asthma: Can the Baseline Total IgE Level Be Used as a Biological Marker to Decide … B Arslan, GP Çetin, M Türk, İ Gülmez, İ Yılmaz International Archives of Allergy and Immunology, 1-7, 2022 | 16 | 2022 |
| Comparison of clinical courses and mortality of connective tissue disease‐associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias F Yıldırım, M Türk, B Bitik, G Erbaş, N Köktürk, Ş Haznedaroğlu, H Türktaş The Kaohsiung journal of medical sciences 35 (6), 365-372, 2019 | 15 | 2019 |
| What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease? I Yilmaz, M Turk American journal of respiratory and critical care medicine 196 (9), 1229-1230, 2017 | 14 | 2017 |
| Combination of omalizumab and bee venom immunotherapy: does it work? İ Yılmaz, SN Bahçecioğlu, M Türk Asia Pacific Allergy 8 (1), e2, 2018 | 13 | 2018 |
| Identification of Chronic Urticaria Subtypes Using Machine Learning Algorithms M Türk, R Ertaş, E Zeydan, Y Türk, M Atasoy, A Gutsche, M Maurer Allergy, 2022 | 12 | 2022 |
| Food-dependent and food-exacerbated symptomatic dermographism: New variants of symptomatic dermographism MB Yücel, R Ertas, M Türk, M Muñoz, M Atasoy, M Maurer Journal of Allergy and Clinical Immunology 149 (2), 788-790, 2022 | 11 | 2022 |
| Effectiveness of as‐needed antihistamines in chronic spontaneous urticaria patients under omalizumab treatment M Türk, İ Yılmaz, SN Bahçecioğlu, P Can, R Ertaş, D Kartal, SL Çınar, ... Dermatologic Therapy, 2020 | 10 | 2020 |
Insu YılmazErciyes University School of Medicine Department of Chest Diseases, Division of Allergy and ClinicalVerified email at erciyes.edu.tr
